BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: The BCL2 family represents an important therapeutic target and determination of the BCL2 family member isoform expression may be a valuable diagnostic tool for patients with CML and other myeloproliferative neoplasms in the clinic.